Immunoproteomic Profiling of Anti-Viral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
UFDI investigators and collaborators at Arizona State University found that the Epstein-Barr virus may have a role in type 1 diabetes development.
All Posts
Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes
UFDI researcher Patrick Concannon, Ph.D. and other collaborators found that four loci were associated with autoantibody positivity at genome-wide significance in type 1 diabetes.
New NIDDK funding opportunities available
Two new NIH/NIDDK funding opportunities have become recently available: From the National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases: Research Using Biosamples and Subjects from Type 1 Diabetes Clinical Studies –Complications (DP3) “The NIDDK seeks to accelerate the pace of scientific research towards…
The Moderating Role of Body Dissatisfaction in the Relationship between ADHD Symptoms and Disordered Eating in Pediatric Overweight and Obesity
UFDI investigator David Janicke, Ph.D. and other UF researchers found that body dissatisfaction and ADHD symptoms in youth were associated with disordered eating.
Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer
UF investigators found that interferon-y (central to antitumor immunity) has multiple negative effects on cell types within the pancreatic cancer microenvironment.
A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation
UF investigators published a paper on dendritic cell activation in the Journal of Materials Chemistry B.
JDRF and the American Diabetes Association, in Collaboration with Multiple Diabetes Organizations Publish New Classification and Staging Approach for Presymptomatic Type 1 Diabetes
JDRF and the American Diabetes Association, announced today that a new classification approach for staging T1D in its earliest presymptomatic stages would be published in the September 24th online version of Diabetes Care.
New four-drug mixture reverses Type 1 diabetes in mice
Call it the scientist’s version of happy hour: A new, four-drug cocktail has shown a novel ability to reverse established Type 1 diabetes in some mice, University of Florida Health researchers have found.
New Report Finds 23 of 25 States with Highest Rates of Obesity are in the South and Midwest
“United States adult obesity rates remained mostly steady―but high―this past year, increasing in Kansas, Minnesota, New Mexico, Ohio and Utah,” according to a report from TFAH and RWJF.
Live interview with UFDI Investigator Michael Haller, M.D. via TrialNet
Dr. Haller currently serves as the Principal Investigator for the TrialNet ATG/GCSF study funded collaboratively by the NIH, the Helmsley Trust, and Sanofi.
